EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities

Soumyajit Biswas, Rekha Rani Kokkanti, Nandita Parida, Atul Anand Bajoria, Srinivas Patnaik

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-07 · 1881 (3) · 189582

DOI: 10.1016/j.bbcan.2026.189582 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-07. Verfasst von Soumyajit Biswas und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Kalinga Institute of Industrial Technology, (KIIT) Deemed to be University, Bhubaneswar 751024, Odisha, India. Hauptthemen laut MEDLINE: Mouth Neoplasms, Cysteine Proteases, Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 130 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cysteine proteases are crucial enzymes regulating protein turnover, apoptosis, signalling, and tissue remodelling, and have emerged as important regulators of the oral epithelial microenvironment with increasing evidence implicating them in the progression of oral potentially malignant disorders (OPMDs) and their potential contribution to malignant transformation toward oral squamous cell carcinoma (OSCC). Dysregulated expression of these enzymes influences key molecular pathways, notably NF-κB, MAPK, protease-activated receptor (PAR) signalling, and apoptotic cascades, although the extent to which individual cysteine proteases act as primary drivers, facilitators of tumour-associated microenvironmental remodelling, or biomarkers of disease progression remains incompletely defined, which govern extracellular matrix remodelling, inflammation, proliferation, migration, and immune evasion, processes associated with malignant progression. Their diagnostic potential is evident through distinct expression patterns in saliva and tissue, suggesting potential utility as adjunct salivary biomarkers for early detection; however, their diagnostic performance relative to established approaches such as toluidine blue staining, autofluorescence imaging, and cytopathological assessment remains to be systematically evaluated. On the therapeutic front, approaches such as selective inhibitors, plant-derived proteases, prodrugs, and multifunctional theranostic agents have been explored experimentally for modulating inflammation, fibrosis, and tumour invasion, while innovative drug delivery strategies aim to increase specificity and reduce systemic toxicity. Nevertheless, most cysteine-protease-targeted interventions remain at preclinical or early translational stages, and clinical validation in oral diseases is currently limited. However, challenges including resistance mechanisms, lack of absolute selectivity, and potential off-target effects necessitate refined computational and experimental strategies for rational inhibitor design. Furthermore, the relative contribution of individual cysteine proteases across different OPMD subtypes remains insufficiently characterized. Future advances lie in validating protease-based biomarkers across diverse populations and embedding them into personalized medicine frameworks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCysteine ProteasesBiomarkers, TumorCarcinoma, Squamous CellHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

Cysteine protease inhibitorsCysteine proteasesOral potentially malignant disorders (OPMDs)Oral squamous cell carcinoma (OSCC)Targeted therapy

Substanzen

Cysteine ProteasesBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Biotechnology, Kalinga Institute of Industrial Technology, (KIIT) Deemed to be University, Bhubaneswar 751024, Odisha, India.
  • Kalinga Institute of Dental Science, Kalinga Institute of Industrial Technology, (KIIT) Deemed to be University, Bhubaneswar 751024, Odisha, India. Electronic address: atultink@gmail.com.
  • School of Biotechnology, Kalinga Institute of Industrial Technology, (KIIT) Deemed to be University, Bhubaneswar 751024, Odisha, India. Electronic address: srinivas.patnaik@kiitbiotech.ac.in.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology

Zitieren

APA

Biswas, S., Kokkanti, R. R., Parida, N., Bajoria, A. A., & Patnaik, S. (2026). Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(3), 189582. https://doi.org/10.1016/j.bbcan.2026.189582

Vancouver

Biswas S, Kokkanti RR, Parida N, Bajoria AA, Patnaik S. Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(3):189582. doi:10.1016/j.bbcan.2026.189582

BibTeX
@article{Biswas2026,
  author = {Biswas, Soumyajit and Kokkanti, Rekha Rani and Parida, Nandita and Bajoria, Atul Anand and Patnaik, Srinivas},
  title = {Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {3},
  pages = {189582},
  doi = {10.1016/j.bbcan.2026.189582}
}
Kostenlos starten →